Index of reports
> Cases with Pyrexia (46)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Depakene (Valproic Acid) where reactions include pyrexia. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 46 Next >>
Possible Depakene side effects in female
Reported by a physician from China on 2012-08-20
Patient: female
Reactions: Drug Eruption, Anaphylactoid Reaction, Swelling, Pyrexia, Rash
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Depakene
Other drugs received by patient: Penicillin
Possible Depakene side effects in female
Reported by a physician from Japan on 2012-08-15
Patient: female
Reactions: Rash Generalised, Lymphocyte Stimulation Test Positive, Pyrexia, Rash, Drug Rash With Eosinophilia and Systemic Symptoms, Periproctitis, Anal Erosion, Generalised Erythema, Gamma-Glutamyltransferase Increased, Human Herpes Virus 6 Serology Positive, Anal Haemorrhage, White Blood Cell Count Increased, Toxic Skin Eruption
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Depakene
Dosage: 1000mg per day
Administration route: Oral
Indication: Epilepsy
Start date: 2010-05-07
Lamictal
Dosage: 50mg per day
Administration route: Oral
Indication: Epilepsy
Start date: 2010-05-10
End date: 2010-06-25
Other drugs received by patient: Clobazam; Tegretol
Possible Depakene side effects in 77 year old male
Reported by a physician from Japan on 2012-08-13
Patient: 77 year old male
Reactions: Drug Eruption, Abdominal Pain, Pruritus, Extravasation Blood, Pyrexia, Erythema, Liver Disorder, Lymphocytic Infiltration, Malaise, Dermatitis, Injection Site Induration, Adrenal Insufficiency, Mycoplasma Test Positive, Erythema Multiforme, Procalcitonin Increased, Mass, Urinary Tract Infection, Blood Potassium Increased, Rash, Delirium, Pigmentation Disorder, Epidermal Necrosis, Insomnia, Human Herpesvirus 6 Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cefaclor
Dosage: unk ukn, unk
Administration route: Oral
Indication: Respiratory Tract Infection
Start date: 2012-04-12
Clarithromycin
Dosage: unk ukn, unk
Administration route: Oral
Indication: Urinary Tract Infection
Start date: 2011-11-29
End date: 2011-12-06
Depakene
Dosage: unk ukn, unk
Administration route: Oral
Indication: Epilepsy
Start date: 2012-04-18
Keppra
Dosage: unk ukn, unk
Administration route: Oral
Indication: Epilepsy
Start date: 2012-04-18
Tegretol
Dosage: unk ukn, unk
Administration route: Oral
Indication: Epilepsy
Start date: 2012-03-16
End date: 2012-04-17
Other drugs received by patient: Teofurmate; Hokunalin; Cyscarbon; Aspirin; Protecadin; Feburic
Possible Depakene side effects in female
Reported by a physician from Brazil on 2012-08-13
Patient: female, weighing 72.0 kg (158.4 pounds)
Reactions: Pneumonia, Pain, Monocytosis, Ovarian Cyst, Neck Mass, Pyrexia, Eye Pain, Dengue Fever, Rash Macular, Lymphocytosis, Generalised Erythema, Oedema Peripheral, Unevaluable Event, Thyroid Neoplasm, Post Procedural Haemorrhage, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Depakene
Administration route: Oral
Indication: Epilepsy
End date: 1998-01-01
Depakene
Administration route: Oral
Start date: 1998-01-01
Depakene
Start date: 2009-01-01
Depakene
Other drugs received by patient: Lamotrigine; Phenobarbital TAB; Atenolol; Clonazepam
Possible Depakene side effects in male
Reported by a physician from Japan on 2012-08-07
Patient: male
Reactions: Pyrexia, Eczema, Lymphocyte Stimulation Test Positive, Oral Mucosa Erosion, Stevens-Johnson Syndrome, LIP Erosion
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Depakene
Dosage: 500mg per day
Administration route: Oral
Indication: Mood Swings
Start date: 2012-01-23
End date: 2012-06-22
Lamictal
Dosage: 12.5mg per day
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2012-05-28
End date: 2012-06-01
Lamictal
Dosage: 25mg per day
Administration route: Oral
Start date: 2012-06-01
End date: 2012-06-22
Topiramate
Dosage: 350mg per day
Administration route: Oral
Indication: Post-Traumatic Stress Disorder
Start date: 2012-01-23
End date: 2012-06-22
Possible Depakene side effects in female
Reported by a physician from Japan on 2012-08-06
Patient: female, weighing 43.0 kg (94.6 pounds)
Reactions: Dermatitis Contact, Pyrexia, Rash, Erythema, Drug Rash With Eosinophilia and Systemic Symptoms, Eosinophilia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Depakene
Dosage: 800mg per day
Administration route: Oral
Indication: Epilepsy
Start date: 2011-03-14
End date: 2011-05-24
Lamictal
Dosage: 25mg per day
Administration route: Oral
Indication: Epilepsy
Start date: 2011-04-05
End date: 2011-05-24
Other drugs received by patient: Cytotec
Possible Depakene side effects in female
Reported by a physician from France on 2012-08-03
Patient: female
Reactions: Anaemia, Pyrexia, Aplasia Pure RED Cell, Conjunctival Pallor
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bactrim
Dosage: 5ml per day
Administration route: Oral
Indication: Prophylaxis
End date: 2012-05-24
Depakene
Dosage: 100mg per day
Administration route: Oral
Indication: Encephalopathy
End date: 2012-05-27
Retrovir
Dosage: 15ml twice per day
Administration route: Oral
Indication: HIV Infection
End date: 2012-05-24
Other drugs received by patient: Viramune; Epivir; Ursolvan
Possible Depakene side effects in 77 year old male
Reported by a physician from Japan on 2012-07-18
Patient: 77 year old male
Reactions: Drug Eruption, Abdominal Pain, Pruritus, Gram Stain Positive, Extravasation Blood, Pyrexia, Erythema, Liver Disorder, Lymphocytic Infiltration, Malaise, Dermatitis, Injection Site Induration, Adrenal Insufficiency, Mycoplasma Test Positive, Erythema Multiforme, Mass, Urinary Tract Infection, Blood Potassium Increased, Rash, Lymphocyte Stimulation Test Positive, Delirium, Pigmentation Disorder, Epidermal Necrosis, Insomnia, Human Herpesvirus 6 Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cefaclor
Dosage: unk ukn, unk
Administration route: Oral
Start date: 2012-04-12
Clarithromycin
Dosage: unk ukn, unk
Administration route: Oral
Start date: 2011-11-29
End date: 2011-12-06
Depakene
Dosage: unk ukn, unk
Administration route: Oral
Start date: 2012-04-18
Keppra
Dosage: unk ukn, unk
Administration route: Oral
Start date: 2012-04-18
Tegretol
Dosage: unk ukn, unk
Administration route: Oral
Indication: Epilepsy
Start date: 2012-03-16
End date: 2012-04-18
Other drugs received by patient: Protecadin; Cyscarbon; Feburic; Hokunalin; Aspirin; Teofurmate
Possible Depakene side effects in 43 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-13
Patient: 43 year old male
Reactions: Cytolytic Hepatitis, Pyrexia, Drug Rash With Eosinophilia and Systemic Symptoms, Toxic Skin Eruption
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Depakene
Other drugs received by patient: Theralene; Pulmicort; Foradil; Loxapine HCL; Ciprofloxacin HCL; Imovane; Ditropan; Tegretol
Possible Depakene side effects in female
Reported by a physician from Japan on 2012-07-10
Patient: female
Reactions: Eye Discharge, Scab, Oropharyngeal Pain, Pyrexia, LIP Erosion, Generalised Erythema, C-Reactive Protein Increased, Dermatitis Bullous, Erythema Multiforme, Monocyte Percentage Increased, Oral Mucosa Erosion, Eosinophil Percentage Increased, Blister, Stevens-Johnson Syndrome, Swelling Face, Erythema of Eyelid, Dysphagia, Vulval Disorder, Pain of Skin, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Toxic Epidermal Necrolysis, Oropharyngeal Discomfort, Epidermal Necrosis, Aspartate Aminotransferase Increased, Ocular Hyperaemia, Skin Erosion, Rash Maculo-Papular
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Depakene
Dosage: 200mg per day
Administration route: Oral
Indication: Depression
Start date: 2011-11-01
End date: 2012-04-30
Depakene
Dosage: 100mg per day
Administration route: Oral
Start date: 2012-05-01
End date: 2012-05-09
Lamictal
Dosage: 25mg per day
Administration route: Oral
Indication: Depression
Start date: 2012-04-23
End date: 2012-04-30
Lamictal
Dosage: 50mg per day
Administration route: Oral
Start date: 2012-05-01
End date: 2012-05-09
Other drugs received by patient: Zoloft; Cymbalta
Possible Depakene side effects in female
Reported by a consumer/non-health professional from Brazil on 2012-07-03
Patient: female, weighing 72.0 kg (158.4 pounds)
Reactions: Pneumonia, Pain, Monocytosis, Ovarian Cyst, Neck Mass, Pyrexia, Rash Macular, Eye Pain, Dengue Fever, Lymphocytosis, Generalised Erythema, Oedema Peripheral, Unevaluable Event, Thyroid Neoplasm, Post Procedural Haemorrhage, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Depakene
Dosage: 2 capsules am and 2 at night
Administration route: Oral
Indication: Epilepsy
Depakene
Dosage: 1 capsule am and 2 at night
Administration route: Oral
Possible Depakene side effects in female
Reported by a pharmacist from Japan on 2012-07-03
Patient: female, weighing 43.0 kg (94.6 pounds)
Reactions: Dermatitis Contact, Pyrexia, Rash, Erythema, Drug Rash With Eosinophilia and Systemic Symptoms, Eosinophilia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Depakene
Dosage: 800mg per day
Administration route: Oral
Indication: Epilepsy
Start date: 2011-03-14
End date: 2011-05-24
Lamictal
Dosage: 25mg per day
Administration route: Oral
Indication: Epilepsy
Start date: 2011-04-05
End date: 2011-05-24
Other drugs received by patient: Cytotec
Possible Depakene side effects in male
Reported by a physician from Japan on 2012-07-02
Patient: male
Reactions: Eyelid Oedema, Lymphadenopathy, Skin Test Positive, Rash, Pyrexia, Drug Rash With Eosinophilia and Systemic Symptoms, Erythema, Skin Lesion, Liver Function Test Abnormal
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Depakene
Dosage: 800mg per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2009-11-09
End date: 2011-05-27
Lamictal
Dosage: 25mg alternate days
Administration route: Oral
Indication: Epilepsy
Start date: 2011-04-28
End date: 2011-05-12
Lamictal
Dosage: 25mg per day
Administration route: Oral
Start date: 2011-05-13
End date: 2011-05-25
Other drugs received by patient: Chinese Medicine; Magmitt; Rohypnol; Depas
Possible Depakene side effects in female
Reported by a physician from Japan on 2012-06-26
Patient: female
Reactions: Drug Eruption, Lymphadenopathy, Hepatic Function Abnormal, Fibrin Degradation Products Increased, Disseminated Intravascular Coagulation, Blood Albumin Decreased, Pyrexia, Malaise, Blood Fibrinogen Decreased, Fibrin D Dimer Increased, C-Reactive Protein Increased, Decreased Appetite, Blood Alkaline Phosphatase Increased, Viral Infection, Kidney Enlargement, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Blood Cholinesterase Decreased, Protein Total Decreased, Local Swelling, Hepatic Enzyme Increased, Varicella Virus Test Positive, Herpes Simplex Serology Positive, Aspartate Aminotransferase Increased, Platelet Count Decreased, Leucine Aminopeptidase Increased, Meningitis Aseptic
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Depakene
Dosage: 600mg per day
Administration route: Oral
Indication: Bipolar II Disorder
Lamictal
Dosage: 25mg twice per day
Administration route: Oral
Indication: Bipolar II Disorder
Start date: 2012-05-07
End date: 2012-05-23
Other drugs received by patient: Dogmatyl; Risperdal; Desyrel; Clonazepam; Pursennid; Magmitt
Possible Depakene side effects in female
Reported by a pharmacist from Japan on 2012-06-20
Patient: female
Reactions: Drug Eruption, Hepatic Function Abnormal, Lymphadenopathy, Fibrin Degradation Products Increased, Disseminated Intravascular Coagulation, Blood Albumin Decreased, Pyrexia, Blood Fibrinogen Decreased, C-Reactive Protein Increased, Fibrin D Dimer Increased, Blood Alkaline Phosphatase Increased, Viral Infection, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Blood Cholinesterase Decreased, Protein Total Decreased, Local Swelling, Hepatic Enzyme Increased, Varicella Virus Test Positive, Herpes Simplex Serology Positive, Aspartate Aminotransferase Increased, Platelet Count Decreased, Leucine Aminopeptidase Increased, Meningitis Aseptic
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Depakene
Dosage: 600mg per day
Administration route: Oral
Indication: Bipolar II Disorder
Lamictal
Dosage: 25mg twice per day
Administration route: Oral
Indication: Bipolar II Disorder
Start date: 2012-05-07
End date: 2012-05-23
Other drugs received by patient: Clonazepam; Dogmatyl; Pursennid; Risperdal; Magmitt; Desyrel
Possible Depakene side effects in female
Reported by a physician from Japan on 2012-06-12
Patient: female
Reactions: Drug Eruption, Hepatic Function Abnormal, Lymphadenopathy, Fibrin Degradation Products Increased, Disseminated Intravascular Coagulation, Blood Albumin Decreased, Pyrexia, Blood Fibrinogen Decreased, Fibrin D Dimer Increased, C-Reactive Protein Increased, Blood Alkaline Phosphatase Increased, Viral Infection, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Blood Cholinesterase Decreased, Protein Total Decreased, Local Swelling, Hepatic Enzyme Increased, Varicella Virus Test Positive, Herpes Simplex Serology Positive, Aspartate Aminotransferase Increased, Platelet Count Decreased, Leucine Aminopeptidase Increased, Meningitis Aseptic
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Depakene
Dosage: 600mg per day
Administration route: Oral
Indication: Bipolar II Disorder
Lamictal
Dosage: 25mg per day
Administration route: Oral
Indication: Bipolar II Disorder
Start date: 2012-05-07
End date: 2012-05-23
Other drugs received by patient: Dogmatyl; Desyrel; Magmitt; Clonazepam; Risperdal; Pursennid
Possible Depakene side effects in female
Reported by a physician from Japan on 2012-06-11
Patient: female
Reactions: Eye Discharge, Scab, Pyrexia, LIP Erosion, Generalised Erythema, C-Reactive Protein Increased, Dermatitis Bullous, Monocyte Percentage Increased, Oral Mucosa Erosion, Erythema Multiforme, Eosinophil Percentage Increased, Stevens-Johnson Syndrome, Blister, Erythema of Eyelid, Vulval Disorder, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Toxic Epidermal Necrolysis, Epidermal Necrosis, Ocular Hyperaemia, Aspartate Aminotransferase Increased, Skin Erosion, Rash Maculo-Papular
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Depakene
Dosage: 200mg per day
Administration route: Oral
Start date: 2011-11-01
End date: 2012-04-22
Depakene
Dosage: 100mg per day
Administration route: Oral
Start date: 2012-04-23
End date: 2012-04-30
Lamictal
Dosage: 25mg per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-04-23
End date: 2012-04-30
Lamictal
Dosage: 50mg per day
Administration route: Oral
Start date: 2012-05-01
End date: 2012-05-08
Other drugs received by patient: Zoloft; Cymbalta
Possible Depakene side effects in 16 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-05
Patient: 16 year old female
Reactions: Face Oedema, Lymphadenopathy, Cytolytic Hepatitis, Pyrexia, Rash, Drug Rash With Eosinophilia and Systemic Symptoms, Eosinophilia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Depakene
Administration route: Oral
Indication: Epilepsy
Start date: 2011-02-16
End date: 2011-02-22
Depakene
Administration route: Oral
Start date: 2011-02-23
End date: 2011-03-16
Lamotrigine
Administration route: Oral
Start date: 2011-03-02
End date: 2011-03-16
Lamotrigine
Administration route: Oral
Start date: 2011-02-23
End date: 2011-03-01
Lamotrigine
Administration route: Oral
Indication: Epilepsy
Start date: 2011-02-16
End date: 2011-02-22
Possible Depakene side effects in female
Reported by a physician from France on 2012-05-31
Patient: female
Reactions: Lymphadenopathy, Pyrexia, Skin Test Positive, Drug Rash With Eosinophilia and Systemic Symptoms, Respiratory Distress, Eosinophilia, Face Oedema, Hepatocellular Injury, Hyperammonaemia, Rash Morbilliform, Rash Maculo-Papular, Leukocytosis, Toxic Skin Eruption, Oxygen Saturation Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Depakene
Administration route: Oral
Indication: Epilepsy
Start date: 2011-02-16
End date: 2011-03-16
Lamictal
Administration route: Oral
Indication: Epilepsy
Start date: 2011-02-16
End date: 2011-03-16
Possible Depakene side effects in female
Reported by a physician from Japan on 2012-05-25
Patient: female
Reactions: Eye Discharge, Scab, Pyrexia, LIP Erosion, Generalised Erythema, C-Reactive Protein Increased, Dermatitis Bullous, Oral Mucosa Erosion, Erythema Multiforme, Monocyte Percentage Increased, Eosinophil Percentage Increased, Blister, Stevens-Johnson Syndrome, Erythema of Eyelid, Vulval Disorder, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Toxic Epidermal Necrolysis, Aspartate Aminotransferase Increased, Ocular Hyperaemia, Epidermal Necrosis, Skin Erosion, Rash Maculo-Papular
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Depakene
Dosage: 200mg per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-11-01
End date: 2012-04-22
Depakene
Dosage: 100mg per day
Administration route: Oral
Start date: 2012-04-23
End date: 2012-04-30
Lamictal
Dosage: 25mg per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-04-23
End date: 2012-04-30
Lamictal
Dosage: 50mg per day
Administration route: Oral
Start date: 2012-05-01
End date: 2012-05-08
Other drugs received by patient: Zoloft; Cymbalta
Possible Depakene side effects in female
Reported by a physician from France on 2012-05-24
Patient: female
Reactions: Pruritus, Lymphadenopathy, Drug Interaction, Pyrexia, Erythema, Face Oedema, Conjunctival Hyperaemia, Dermatitis Bullous, Skin Disorder, Toxic Epidermal Necrolysis, Vulvar Erosion, Nikolsky's Sign, Mucosal Erosion, Respiratory Tract Congestion, Lacrimation Increased, Rash Maculo-Papular, Toxic Skin Eruption, Keratitis, Inflammation
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Depakene
Administration route: Oral
Indication: Epilepsy
Start date: 2008-12-21
End date: 2009-04-18
Lamictal
Administration route: Oral
Indication: Epilepsy
Start date: 2009-03-31
End date: 2009-04-15
Other drugs received by patient: Norlevo; Clobazam
Possible Depakene side effects in 51 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-16
Patient: 51 year old male
Reactions: Tubulointerstitial Nephritis, General Physical Condition Abnormal, Cholestasis, Hypervolaemia, Pyrexia, Renal Hypertrophy, Transaminases Increased, Pericardial Effusion, Nephrotic Syndrome, Ascites, Renal Failure, Glomerulonephritis, Oedema Peripheral, Pleural Effusion, Systemic Inflammatory Response Syndrome, Renal Tubular Necrosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Depakene
Dosage: 500 mg, bid
Administration route: Oral
End date: 2011-08-01
Keppra
Dosage: 500 mg, bid
Administration route: Oral
Tegretol
Dosage: 400 mg, bid
Administration route: Oral
Start date: 2011-08-02
End date: 2011-11-02
Possible Depakene side effects in 14 year old female
Reported by a individual with unspecified qualification from France on 2012-04-26
Patient: 14 year old female
Reactions: Dilatation Ventricular, Pseudomonas Infection, Pulmonary Arterial Hypertension, Pulmonary Embolism, Pyrexia, Staphylococcal Sepsis, Drug Rash With Eosinophilia and Systemic Symptoms, Prurigo, Toxic Skin Eruption
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Depakene
Dosage: po
Administration route: Oral
Indication: Epilepsy
Start date: 2011-12-26
Desloratadine
Dosage: po; po
Administration route: Oral
Indication: Rash
Start date: 2011-12-26
Desloratadine
Dosage: po; po
Administration route: Oral
Indication: Rash
Start date: 2011-12-03
Lamictal
Dosage: 100 mg; bid; po, po
Administration route: Oral
Indication: Epilepsy
Start date: 2011-12-20
End date: 2011-12-22
Lamictal
Dosage: 100 mg; bid; po, po
Administration route: Oral
Indication: Epilepsy
Start date: 2011-11-07
End date: 2011-12-20
Valium
Dosage: po
Administration route: Oral
Indication: Epilepsy
Start date: 2011-12-22
Other drugs received by patient: Prednisolone
Possible Depakene side effects in female
Reported by a physician from Japan on 2012-04-17
Patient: female
Reactions: Drug Eruption, Swelling Face, Rash Generalised, Chills, Pyrexia, Rash, Erythema, Myalgia, Malaise, Generalised Erythema, Erythema Multiforme, Toxic Skin Eruption
Drug(s) suspected as cause:
Depakene
Dosage: 600mg per day
Administration route: Oral
Indication: Depression
Start date: 2012-01-25
End date: 2012-02-08
Gasmotin
Dosage: 10mg per day
Administration route: Oral
Indication: Prophylaxis
Start date: 2011-08-30
Lamictal
Dosage: 25mg alternate days
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2012-02-08
End date: 2012-02-18
Lexapro
Dosage: 10mg per day
Administration route: Oral
Indication: Depression
Start date: 2011-12-28
End date: 2012-02-21
Paxil
Dosage: 20mg per day
Administration route: Oral
Indication: Depression
Start date: 2011-08-30
Rize
Dosage: 15mg per day
Administration route: Oral
Indication: Anxiety
Start date: 2011-08-30
Possible Depakene side effects in female
Reported by a lawyer from France on 2012-04-11
Patient: female
Reactions: Productive Cough, Weight Decreased, Eyelid Oedema, LIP Disorder, Ulcerative Keratitis, Visual Acuity Reduced, Pyrexia, Oral Mucosal Exfoliation, Blister, Stomatitis, Dysphagia, Mouth Haemorrhage, Toxic Epidermal Necrolysis, Corneal Opacity, Dermal Cyst, Pigmentation LIP, Keratitis, Eye Discharge, Corneal Perforation, Symblepharon, Mouth Ulceration, Conjunctivitis, Fatigue, Skin Discolouration, Photophobia, Iris Incarceration, Rash Papular, Incorrect Dose Administered, Skin Disorder, Hernia, Eye Pain, Mucosal Erosion, Alopecia, Pigmentation Disorder, Itching Scar, Corneal Oedema, Eye Excision, Blindness
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Depakene
Dosage: 750mg twice per day
Administration route: Oral
Indication: Epilepsy
Start date: 2008-05-01
End date: 2010-02-14
Lamictal
Administration route: Oral
Indication: Epilepsy
Start date: 2010-01-19
End date: 2010-02-13
Possible Depakene side effects in male
Reported by a physician from Japan on 2012-03-28
Patient: male
Reactions: Skin Exfoliation, Eye Discharge, Hyperthermia, Oropharyngeal Pain, Pyrexia, Erythema, Somnolence, LIP Erosion, Cheilitis, Malaise, Conjunctival Hyperaemia, Dizziness, Stevens-Johnson Syndrome, Erythema of Eyelid, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Rash Papular, Rash, Oral Mucosal Erythema, Aspartate Aminotransferase Increased, Epidermal Necrosis, Rash Maculo-Papular
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Depakene
Dosage: 400mg per day
Administration route: Oral
Indication: Bipolar I Disorder
Start date: 2011-04-02
End date: 2011-07-26
Lamictal
Dosage: 25mg alternate days
Administration route: Oral
Indication: Bipolar I Disorder
Start date: 2011-06-16
Lamictal
Dosage: 50mg per day
Administration route: Oral
End date: 2011-07-19
Other drugs received by patient: Zolpidem; Flunitrazepam; Paxil; Sennoside; Allopurinol; U PAN; Lithium Carbonate; Desyrel
Possible Depakene side effects in 21 year old female
Reported by a consumer/non-health professional from Spain on 2012-03-15
Patient: 21 year old female
Reactions: Rash Erythematous, Drug Interaction, Pyrexia, Respiratory Distress
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Depakene
Other drugs received by patient possibly interacting with the suspect drug: Lamotrigine
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-20
End date: 2012-01-22
Possible Depakene side effects in 21 year old female
Reported by a physician from Spain on 2012-03-14
Patient: 21 year old female
Reactions: Vomiting, Nausea, Hypotension, Pyrexia, Respiratory Distress, Menstrual Disorder, Skin Lesion, Rash Erythematous
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Depakene
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-07-20
Lamictal
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-13
End date: 2012-01-22
Possible Depakene side effects in 23 year old female
Reported by a physician from Japan on 2012-03-07
Patient: 23 year old female
Reactions: Atelectasis, Pneumonia Aspiration, Intentional Overdose, Coma, Laceration, Pyrexia, Intentional Self-Injury, Somnolence, Suicidal Ideation, Anticonvulsant Drug Level Increased, Multiple Drug Overdose Intentional, Sputum Increased, Altered State of Consciousness, Medication Residue, Respiration Abnormal
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Depakene
Dosage: 4200 mg, unk
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2009-09-11
Lithium Carbonate
Dosage: 5600 mg, unk
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2009-09-11
Risperdal
Dosage: 7 mg, unk
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2009-09-11
Tegretol
Dosage: 4200 mg, daily
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2009-09-11
Other drugs received by patient: Alcohol
Possible Depakene side effects in 29 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-02-28
Patient: 29 year old male
Reactions: Confusional State, Tachycardia, Pyrexia, Somnolence, Muscle Rigidity, Overdose, Gait Disturbance, Altered State of Consciousness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clopixol
Start date: 2011-11-01
Clopixol
Indication: Childhood Psychosis
Start date: 2009-07-01
Depakene
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-13
Lepticur
Lepticur
Indication: Product Used FOR Unknown Indication
Start date: 2006-07-01
Nozinan
Administration route: Oral
Indication: Childhood Psychosis
Start date: 2011-11-01
Tranxene
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-23
Trimeprazine Tartrate
Dosage: 30 drops daily
Administration route: Oral
Indication: Childhood Psychosis
Start date: 2006-07-01
Trimeprazine Tartrate
Dosage: 30 drops daily
Administration route: Oral
Start date: 2011-11-01
Other drugs received by patient: Tercian; Loxapine HCL
Page 1 Next >>
|